Answer:
Explanation:
Cellular respiration is a process which occurs in the all living cell all the time. It is an oxidative process by which respiratory substrate such as glucose (C₆H₁₂O₆) is oxidised completely in presence of oxygen(O₂) to produce carbon dioxide (CO₂), water and energy in the from of ATP. ATP is is the energy currency of the cell. The process of cellular respiration begins in cytoplasm and completes in the mitochondria of the cell.
The overall reaction of respiration is given below:
C₆H₁₂O₆+ 6O₂ → 6CO₂+ 6H₂O + Energy (ATP)
State of demographic transition of all countries dictates the growth rate of global population and how close we are to carrying capacity
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Answer:
trees because they change,birds they change
Explanation:
